Skip navigation

Refine by Type

Results 1 - 10 of 27 for SUNITINIB
  1. Sunitinib is used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the ... imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal cell ...
  2. Targeted Therapies for Kidney Cancer (American Cancer Society)  
    ... or soles of the feet (hand-foot syndrome). Sunitinib (Sutent ® ) Sunitinib also blocks several tyrosine kinases, but not the ... cancers after other drugs such as sorafenib or sunitinib have been tried. Everolimus is taken as a ...
  3. ... with imatinib-resistant tumors are then treated with sunitinib (Sutent®), but the disease usually develops resistance to sunitinib and progresses within 1 year. Patients with advanced ...
  4. ... thyroid cancer in clinical trials include sorafenib (Nexavar ® ), sunitinib (Sutent ® ), pazopanib (Votrient ® ), cabozantinib (Cometriq), motesanib (AMG 706), ... of the disease. Some other TKIs, such as sunitinib, sorafenib, and pazopanib, are already approved to treat ...
  5. Angiogenesis Inhibitors From the National Institutes of Health (National Cancer Institute)  
    ... VEGF receptor. Other angiogenesis inhibitors, including sorafenib and sunitinib, bind to receptors on the surface of endothelial ... drugs that have antiangiogenic activity, including sorafenib ( Nexavar ®), sunitinib ( Sutent ®), pazopanib ( Votrient ®), and everolimus ( Afinitor ®). Sorafenib is ...
  6. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... that is involved in cell growth and division. Sunitinib (Sutent®) is another small-molecule tyrosine kinase inhibitor ... by surgery, are locally advanced, or have metastasized. Sunitinib blocks kinases involved in VEGF signaling, thereby inhibiting ...
  7. ... Doctors know targeted treatments like imatinib (Gleevec ® ) and sunitinib (Sutent ® ) often work, but they still aren’t ... period after which they can be stopped? Would sunitinib be as effective as imatinib if it was ...
  8. Drugs Approved for Soft Tissue Sarcoma From the National Institutes of Health (National Cancer Institute)  
    ... Gleevec (Imatinib Mesylate) Imatinib Mesylate Regorafenib Stivarga (Regorafenib) Sunitinib Malate Sutent (Sunitinib Malate) Drugs Approved for Rhabdomyosarcoma ...
  9. Therapies for Advanced Kidney Cancer (Kidney Cancer Association)  
    ... in more than a decade: sorafenib tosylate and sunitinib malate. Both of these new drugs disrupt the ... Nexavar, compared with patients taking a placebo. Sutent® (sunitinib malate) also deprives tumor cells of the blood ...
  10. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Sterile Talc Powder (Talc) Steritalc (Talc) Stivarga (Regorafenib) Sunitinib Malate Sutent (Sunitinib Malate) Sylatron (Peginterferon Alfa-2b) Synovir (Thalidomide) Synribo ( ...
previous · 1 · 2 · 3 · next